Prostate Cancer

Whole-exome Sequencing of Nigerian Prostate Tumors from the Prostate Cancer Transatlantic Consortium (CaPTC) Reveals DNA Repair Genes Associated with African Ancestry. March 24, 2023

A hotspot for posttranslational modifications on the androgen receptor dimer interface drives pathology and anti-androgen resistance. March 24, 2023

Treatment of prostate cancer with CD46 targeted 225Ac alpha particle radioimmunotherapy. March 24, 2023

Immune and pathologic responses in patients with localized prostate cancer who received daratumumab (anti-CD38) or edicotinib (CSF-1R inhibitor). March 24, 2023

Phase 1 Study of Safety and Preliminary Clinical Activity of JNJ-63898081, a PSMA and CD3 Bispecific Antibody, for Metastatic Castration-Resistant Prostate Cancer. March 24, 2023

First-in-human, phase 1 study of PF-06753512, a vaccine-based immunotherapy regimen (VBIR), in non-metastatic hormone-sensitive biochemical recurrence and metastatic castration-resistant prostate cancer (mCRPC). March 24, 2023

Simultaneous hernia repair following robotic-assisted radical prostatectomy is safe with low rates of mesh-related complications. March 24, 2023

Proton therapy for high-risk prostate cancer: Results from the Proton Collaborative Group PCG 001-09 prospective registry trial. March 24, 2023

Targeting the chromatin effector Pygo2 promotes cytotoxic T cell responses and overcomes immunotherapy resistance in prostate cancer. March 24, 2023

Potent Stimulation of the Androgen Receptor Instigates a Viral Mimicry Response in Prostate Cancer. March 24, 2023

Systematic or targeted fusion-guided biopsy. March 23, 2023

A pair of deep learning auto-contouring models for prostate cancer patients injected with a radio-transparent versus radiopaque hydrogel spacer. March 23, 2023

Integrating radium-223 therapy into the management of metastatic prostate cancer care: a plain language summary. March 23, 2023

Preoperative endogenous total testosterone predicts prostate cancer progression: results in 580 consecutive patients treated with robot assisted radical prostatectomy for clinically localized disease. March 23, 2023

Impact of prostate MRI central review over the diagnostic performance of MRI-targeted biopsy: should we routinely ask for an expert second opinion? March 23, 2023

Pretest Genetic Education Video Versus Genetic Counseling for Men Considering Prostate Cancer Germline Testing: A Patient-Choice Study to Address Urgent Practice Needs. March 23, 2023

Palette Life Sciences Announces Transaction with Global Healthcare Investor OrbiMed March 22, 2023

Understanding the sexual health perceptions, concerns, and needs of female partners of prostate cancer survivors. March 22, 2023

Characterization of high-grade prostate cancer at multiparametric MRI: assessment of PI-RADS version 2.1 and version 2 descriptors across 21 readers with varying experience (MULTI study). March 22, 2023

Expression and therapeutic targeting of Trop-2 in treatment resistant prostate cancer. March 22, 2023

Page 1 of 1288